Yellon DM - Search Results

1

Glucagon-like peptide-1 (GLP-1) receptor activation dilates cerebral arterioles, increases cerebral blood flow, and mediates remote (pre)conditioning neuroprotection against ischaemic stroke.

Nizari S, Basalay M, Chapman P, Korte N, Korsak A, Christie IN, Theparambil SM, Davidson SM, Reimann F, Trapp S, Yellon DM, Gourine AV. Nizari S, et al. Among authors: yellon dm. Basic Res Cardiol. 2021 May 3;116(1):32. doi: 10.1007/s00395-021-00873-9. Basic Res Cardiol. 2021. PMID: 33942194 Free PMC article.

2

Heat shock protein 27 protects the heart against myocardial infarction.

Efthymiou CA, Mocanu MM, de Belleroche J, Wells DJ, Latchmann DS, Yellon DM. Efthymiou CA, et al. Among authors: yellon dm. Basic Res Cardiol. 2004 Nov;99(6):392-4. doi: 10.1007/s00395-004-0483-6. Epub 2004 Jul 13. Basic Res Cardiol. 2004. PMID: 15309411

3

Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury.

Bose AK, Mocanu MM, Carr RD, Brand CL, Yellon DM. Bose AK, et al. Among authors: yellon dm. Diabetes. 2005 Jan;54(1):146-51. doi: 10.2337/diabetes.54.1.146. Diabetes. 2005. PMID: 15616022

4

The role of nitric oxide in mitochondria. Focus on "Modulation of mitochondrial Ca2+ by nitric oxide in cultured bovine vascular endothelial cells".

Davidson SM, Yellon DM. Davidson SM, et al. Among authors: yellon dm. Am J Physiol Cell Physiol. 2005 Oct;289(4):C775-7. doi: 10.1152/ajpcell.00277.2005. Am J Physiol Cell Physiol. 2005. PMID: 16157689 Free article. No abstract available.

5

Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection.

Davidson SM, Hausenloy D, Duchen MR, Yellon DM. Davidson SM, et al. Among authors: yellon dm. Int J Biochem Cell Biol. 2006 Mar;38(3):414-9. doi: 10.1016/j.biocel.2005.09.017. Epub 2005 Oct 21. Int J Biochem Cell Biol. 2006. PMID: 16280253

6

Does hyperglycemia reduce proliferation or increase apoptosis?

Davidson SM, Yellon DM. Davidson SM, et al. Among authors: yellon dm. Am J Physiol Heart Circ Physiol. 2006 Sep;291(3):H1486; author reply H1487. doi: 10.1152/ajpheart.00301.2006. Epub 2006 Apr 14. Am J Physiol Heart Circ Physiol. 2006. PMID: 16617134 Free article. No abstract available.

7

Dissecting out the mechanism of cardioprotection by endogenous erthyropoietin using genetic engineering.

Davidson SM, Yellon DM. Davidson SM, et al. Among authors: yellon dm. Cardiovasc Res. 2006 Aug 1;71(3):408-10. doi: 10.1016/j.cardiores.2006.06.007. Epub 2006 Jun 14. Cardiovasc Res. 2006. PMID: 16822493 No abstract available.

8

Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore.

Lim SY, Davidson SM, Hausenloy DJ, Yellon DM. Lim SY, et al. Among authors: yellon dm. Cardiovasc Res. 2007 Aug 1;75(3):530-5. doi: 10.1016/j.cardiores.2007.04.022. Epub 2007 May 4. Cardiovasc Res. 2007. PMID: 17512507 Free PMC article.

9

Ischemic preconditioning targets the reperfusion phase.

Hausenloy DJ, Wynne AM, Yellon DM. Hausenloy DJ, et al. Among authors: yellon dm. Basic Res Cardiol. 2007 Sep;102(5):445-52. doi: 10.1007/s00395-007-0656-1. Epub 2007 May 29. Basic Res Cardiol. 2007. PMID: 17530316

10

Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathway.

Bose AK, Mocanu MM, Carr RD, Yellon DM. Bose AK, et al. Among authors: yellon dm. Cardiovasc Drugs Ther. 2007 Aug;21(4):253-6. doi: 10.1007/s10557-007-6030-6. Cardiovasc Drugs Ther. 2007. PMID: 17541736

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

484 results

Search Page

Filters